Kuros Biosciences Ltd. - Earnings Release 2011

News Details

Corporate | 28 April 2011 07:00

Cytos Biotechnology First Quarter Report 2011

Cytos Biotechnology AG / Key word(s): Quarter Results

28.04.2011 / 07:00

Cytos Biotechnology Ltd First Quarter Report 2011 as of March 31, 2011

Summary of important events in Q1 2011

United States Army and Cytos Biotechnology collaborate on malaria vaccines research
Cytos Biotechnology receives EU funding to work on novel vaccine approaches for emerging viral diseases
Cytos Biotechnology presented latest data on the mechanism of action of QbG10 for the treatment of allergic asthma at the 3rd International Conference on Drug Discovery and Therapy in Dubai
Upcoming event:
- Presentation at the Active Immunotherapeutics Forum, May 11-13, 2011 in Barcelona, Spain
Financial summary


in CHF million	Q1 2011	Q1 2010
Revenue	0.6	0.3
Net operating costs	(5.5)	(6.9)
Net loss	(5.3)	(3.8)

	03/31/11	12/31/10
Cash, cash equivalents,	42.0	48.7
financial assets
and trade and other receivables

Convertible bonds	41.1	41.1
(outstanding nominal value)

Full-time equivalents (number)	75	81

The complete First Quarter Report 2011 can be downloaded on Cytos Biotechnology's website under the following link:

For more information please contact:

Harry Welten, MBA

Chief Financial Officer

Cytos Biotechnology Ltd

Wagistrasse 25, Postfach

CH-8952 Schlieren (Zurich)

Tel. +41 44 733 46 46

End of Corporate News

28.04.2011 News transmitted by EquityStory AG.

The issuer is responsible for the contents of the release.

EquityStory publishes regulatory releases, media releases on the capital market and press releases.

The EquityStory Group distributes authentic and real-time financial news for over 1’300 listed companies.

The Swiss news archive can be found at http://www.equitystory.ch/nachrichten


Language:	English
Company:	Cytos Biotechnology AG
	Wagistr. 25
	8952 Schlieren
	Schweiz
Phone:	+41 44 733 4747
Fax:	+41 44 733 4740
E-mail:	[email protected]
Internet:	www.cytos.com
ISIN:	CH0011025217, CH0029060735
Swiss Security Number:	–
Listed:	Regulierter Markt in SIX; Freiverkehr in Berlin, München, Stuttgart; Open Market in Frankfurt



End of News	EquityStory AG News-Service


- - -
121664 28.04.2011

AI assistant